You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 3, March 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  EDITORIAL REVIEW
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cyclosporine

An Immunosuppressant Affecting Epithelial Cell Proliferation

Jean Kanitakis, MD; Jean Thivolet, MD

Arch Dermatol. 1990;126(3):369-375.


Abstract

• Cyclosporine (cyclosporin A) is an immunosuppressant that selectively acts on the CD4+ subset of T lymphocytes. Recent results of experimental in vitro and in vivo studies, as well as evidence obtained through the clinical use of cyclosporine in humans, strongly suggest that cyclosporine may exert a direct effect on the growth of several epithelial cell types. Thus, cyclosporine, while stimulating the growth of hair follicle keratinocytes with a resulting hypertrichosis, appears to exert a cytostatic effect on several epithelial cell types of human and animal origin. This antiproliferative effect is shared by some minimally immunosuppressive or nonimmunosuppressive cyclosporine analogues, suggesting that the molecular mechanisms that modulate epithelial cell growth differ from those responsible for immunosuppression. This newly discovered pharmacologic property of cyclosporine may hopefully lead to the wider use of nonimmunosuppressive cyclosporines in the treatment of hyperproliferative epidermal diseases.

(Arch Dermatol. 1990;126:369-375)



Author Affiliations

From the INSERM U 209, Clinique Dermatologique, Hôpital Ed. Herriot, Lyon, France.


Footnotes

Accepted for publication September 28, 1989.

Reprint requests to INSERM U 209, Clinique Dermatologique, Hôpital Ed. Herriot, 69437 Lyon, France (Dr Kanitakis).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Drug points: Erythromelalgia induced by possible calcium channel blockade by ciclosporin
Thami and Bhalla
BMJ 2003;326:910-910.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.